Can we improve patient outcomes through using evidence-based opioid deprescribing guidelines to reduce opioid use?

Aili V. Langford, Carl R. Schneider, Chung Wei Christine Lin, Danijela Gnjidic

Research output: Contribution to journalLetterOtherpeer-review


We commend Hallvik et al. on their recent cohort study of Oregon Medicaid recipients on high-dose chronic opioid treatment, in which an increased risk of serious patient harms after both opioid continuation and discontinuation was observed. The increased incidence of suicide and illicit opioid use after opioid reduction is concerning, as is the increased risk of fatal overdose for individuals with stable or increasing opioid doses.
Original languageEnglish
Pages (from-to)e382-e382
Number of pages1
Issue number2
Publication statusPublished - Feb 2022
Externally publishedYes

Cite this